Sort
82,697 grants matching “vaccine development”
Integrated Services Core
$895,766William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2025 · AI
HANTAVIRUS ECOLOGY AND DISEASE IN CHILE AND PANAMA
$895,759University Of New Mexico · U19 · FY2005 · AI
Non-Human Primate Core
$895,730Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2016 · AI
Development of Novel Therapeutic Agents for Norovirus Infection
$895,635Kyeong-Ok Chang · Kansas State University · U01 · FY2013 · AI
Malaria Parasite Ligands And Host Cell Receptors
$895,579Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
$895,539Gary Fanger · Rise Therapeutics, Llc · R44 · FY2021 · DK
NLM's Personal Health Record and Consumer Service R&D
$895,449Clement McDonald · National Library Of Medicine · ZIA · FY2013 · LM
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$895,395Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Entry and replication of positive-sense, RNA viruses
$895,330Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Core 2: BSL-3 Practices Core
$895,157Scott Alderman · Duke University · UC7 · FY2024 · AI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$895,104Thomas G Bernhardt · Harvard Medical School · U19 · FY2016 · AI
Development of PSMA -based recombinant protein vaccines
$895,094Gerald P Donovan · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · CA
Partnership for Detection of Infection by Category B Pathogens
$895,035Frances S. Ligler · U.S. Naval Research Laboratory · U01 · FY2008 · AI
Development of IMPDH-Targeted Drugs against Crytosporidium
$895,013Lizbeth K. Hedstrom · Brandeis University · U01 · FY2009 · AI
Protease-resistant D-peptide Inhibitors of Ebola Virus Entry
$894,941Brett D Welch · Navigen, Inc. · R44 · FY2017 · AI
Frameshift peptide vaccine for the prevention Lynch syndrome-associated gastrointestinal cancer HHSN2612015000391 TORFP: 2018-E12 POP: 9/17/2018 to 3/16/2021
$894,832Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · N01 · FY2018 · CA
Antibody Based Therapeuticcs for Chikungunya Virus
$894,815Michael S. Diamond · Washington University · R01 · FY2013 · AI
A novel strategy for vaccine-induced protection against maternal-to-fetal transmission of Zika virus
$894,640Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2024 · AI
CAREER: Deciphering the nanoparticle-lymphatic vessel interface for modulating immunity
$894,572Katharina Maisel · University Of Maryland, College Park · · FY2021 · MPS
SEQUENCE AND POLYMORPHISM OF RHESUS MACAQUE MHC
$894,547Fred Hutchinson Cancer Research Center · R24 · FY2004 · RR
Development of the Next Generation of Conjugate Vaccines
$894,543Luc Teyton · Scripps Research Institute, The · R01 · FY2018 · AI
Identification of the Initial Targets of Transmission
$894,537Thomas Hope · Northwestern University At Chicago · R37 · FY2023 · AI
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$894,422University Of Louisiana At Lafayette · U42 · FY2004 · RR
Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research
$894,342Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2021 · OD
INNATE IMMUNE RESPPONSE TO MICROBIAL INFECTION
$894,121University Of Iowa · P01 · FY2001 · AI